Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PF) Current Deferred Revenue (2020 - 2025)

Metlife has reported Current Deferred Revenue over the past 6 years, most recently at $5.2 billion for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $5.2 billion for Q4 2025, up 11.37% from a year ago — trailing twelve months through Dec 2025 was $5.2 billion (up 11.37% YoY), and the annual figure for FY2025 was $5.2 billion, up 11.37%.
  • Current Deferred Revenue for Q4 2025 was $5.2 billion at Metlife, up from $5.1 billion in the prior quarter.
  • Over the last five years, Current Deferred Revenue for MET-PF hit a ceiling of $5.2 billion in Q4 2025 and a floor of $3.6 billion in Q4 2021.
  • Median Current Deferred Revenue over the past 5 years was $4.6 billion (2023), compared with a mean of $4.4 billion.
  • Biggest five-year swings in Current Deferred Revenue: grew 17.22% in 2023 and later rose 2.16% in 2024.
  • Metlife's Current Deferred Revenue stood at $3.6 billion in 2021, then rose by 13.27% to $4.1 billion in 2022, then grew by 10.5% to $4.5 billion in 2023, then grew by 2.16% to $4.6 billion in 2024, then increased by 11.37% to $5.2 billion in 2025.
  • The last three reported values for Current Deferred Revenue were $5.2 billion (Q4 2025), $5.1 billion (Q3 2025), and $4.9 billion (Q2 2025) per Business Quant data.